SP182MELATONIN PROMOTED RENAL REGENERATION IN FOLIC ACID-INDUCED ACUTE KIDNEY INJURY VIA INHIBITING NUCLEOCYTOPLASMIC TRANSLOCATION OF HMGB1 IN TUBULAR EPITHELIAL CELLS
INTRODUCTION AND AIMS: Melatonin (N-acetyl-5-methoxytryptamine), a circadian-regulating hormone, has been reported to exert a protective role during acute kidney injury (AKI) induced by renal ischemia-reperfusion injury (I/R). High-mobility group box 1 (HMGB1) is a novel member of the damage-associated molecular pattern (DAMP) family, and has been verified to be an inflammatory cytokine mediating AKI induced by I/R and cisplatin. However, the effect of melatonin on HMGB1, and the relationship of these two with folic acid induced kidney injury are elusive. In this study, we aimed to explore the role of melatonin on folic acid induced AKI and the association with HMGB1. METHODS: One week after melatonin pretreatment, folic acid was injected intraperitoneally to induce AKI in male C57BL/6 mice. RESULTS: Pretreatment with melatonin significantly attenuated folic acid-induced increase in serum creatinine and BUN levels, renal tubular epithelial cell (TEC) apoptosis, and the infiltration of inflammatory cells and secretion of cytokines. Moreover, melatonin pretreatment promoted renal tubular proliferation and improved cell cycle arrest of TECs after folic acid-induced renal damage. CONCLUSIONS: Melatonin protected against folic acid-induced AKI and this protective role was closely related to the inhibition of nucleocytoplasmic translocation of HMGB1 in TECs. These data provide a strong proof that administering melatonin prior to folic acid insult may shed light on a potential treatment for AKI.